Cargando…
Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines
Combined bezafibrate (BEZ) and medroxyprogesterone acetate (MPA) exert unexpected antileukaemic activities against acute myeloid leukaemia (AML) and these activities are associated with the generation of reactive oxygen species (ROS) within the tumor cells. Although the generation of ROS by these dr...
Autores principales: | Tiziani, Stefano, Lodi, Alessia, Khanim, Farhat L., Viant, Mark R., Bunce, Christopher M., Günther, Ulrich L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621336/ https://www.ncbi.nlm.nih.gov/pubmed/19158949 http://dx.doi.org/10.1371/journal.pone.0004251 |
Ejemplares similares
-
Correction: Metabolomic Profiling of Drug Responses in Acute Myeloid Leukaemia Cell Lines
por: Tiziani, Stefano, et al.
Publicado: (2009) -
Hypoxia Triggers Major Metabolic Changes in AML Cells without Altering Indomethacin-Induced TCA Cycle Deregulation
por: Lodi, Alessia, et al.
Publicado: (2010) -
Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
por: Khanim, Farhat L., et al.
Publicado: (2009) -
Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease
por: Lodi, Alessia, et al.
Publicado: (2013) -
Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells
por: Reed, Michelle A. C., et al.
Publicado: (2016)